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Background: The progressive decline in the immune function during ageing is termed immunosenescence.
Previous studies have reported differences between males and females in the distribution and cell responses of
lymphocyte subsets. Most studies of immunosenescence have been done in populations of industrialized countries
living in a rather cold environment, and facing lower antigenic challenges such as Cytomegalovirus (CMV). The aim
of this study was to determine the effect of ageing on lymphocytes in a population with a high prevalence of CMV
infection in all ages, and to compare gender differences related to the immunosenescence markers.
Results: Different populations of peripheral blood leukocytes from healthy young and old IgG-CMV seropositive
individuals were examined using flow cytometry. With age, the number and frequency of B cells and T cells
significantly decreased, while highly differentiated T cells increased. Such changes were different in males and
females. The age-associated decline of less differentiated lymphocyte subsets (CD19, CD4 and CD8 cells) and the
increase of highly differentiated T cells were more prominent in females. In males, there were no significant
changes in CD19, CD4 and CD8 subsets but there was a significant increase in the proportion of highly
differentiated T cells.
Conclusion: Shifts in lymphocyte subsets distribution were influenced by age and gender in an IgG-CMV
seropositive population. These results suggest different patterns of immunosenescence in respect to gender
differences. These patterns could have implications in the design of immunotherapy in the elderly.Introduction
The function of the immune system declines with age
leading to increased susceptibility to infectious diseases,
cancer and poor response to vaccination [1,2]. This decline
is termed “Immunosenescence” [3].
Immunosenescence is related to thymus involution,
reduction in the generation of naïve T-cell populations,
changes in the peripheral T lymphocyte compartments
and reduced functional immune competence. The nature
of these changes is associated with exposure to environ-
mental challenges, such as stress and pathogens [4].
Age-associated changes in lymphocyte subpopulations
have been documented in diverse contexts. The Swedish
octogenarian study (OCTO-immune), showed an increa-
sing number of individuals with CD4:CD8 ratio less than
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distribution, and reproduction in any mediumexpansion of CD8 T cells. The increase in CD8 and its
relationship with cytomegalovirus (CMV) infection suggest
that the infection with this virus might be a contributor to
this significant expansion of CD8 T cells [5].
In Britain, Akbar and coworkers identified the progres-
sive stages in T cell differentiation by sequential changes
in the expression of surface markers, such as CD45RA,
CD28, CD27, and CCR7 [6]. The proportion of most
differentiated T cells in both CD4+ and CD8+ populations,
were designated as CD28-, CD27-, CCR7- by another
group in France [7].
Age-related changes in CD4 T cells have been less docu-
mented than in CD8 cells. However, there is also evidence
of an increase of CD45RA+CD27-CD4+ T cells in older
subjects [8], especially in CMV-infected subjects. These
cells are mostly CMV-specific, but there is also an increase
in effector CD4+ T cells that are specific for other viruses,
i.e. EBV, HSV, and VZV [8].Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
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http://www.immunityageing.com/content/10/1/16One of the fundamental manifestations of immuno-
senescence is a steady decrease of functional thymus
tissue which begins after birth, accelerates with puberty
and is almost completed by the age of 50 [9,10]. A
dramatic decline in peripheral naïve T cells in both,
CD4+ and CD8+ subsets, have been observed in elder
people [11]. The kinetics of thymus involution could be
related to the genetic background of human populations
and is also influenced by sex hormones, such as estrogen
and testosterone. The thymus made fewer new cells with
age in both sexes, but women still had higher levels of
new T cells than men of the same age [12]. Epidemio-
logical differences between sexes (such as weight, life-
style, smoking, and medication) could also account for
differences observed [13].
Recent studies in healthy humans considered the
differences in immunosenescence between males and
females [14,15].
Additionally, immunosenescence is at least partially
driven by the chronic antigenic load, which is obviously
different in diverse environments. These facts support
the hypothesis that the kinetics of immunosenescence
could be different in each country and therefore should
be characterized in every specific context as part of the
information needed for a scientifically based public health
policy, especially in countries with aged populations.
Most studies attempting to assess immunosenescence
have focused on a single population, mostly “WEIRD”
(ie Western, educated, industrialized, rich, democratic).
These are not necessarily representative of the majority
of the world’s population [16]. There is a scarcity of data
about immunosenescence in developing countries and
tropical climate.
This article presents findings from a Cuban population
study aimed to investigate the effect of age and gender
on lymphocyte populations in healthy humans. More-
over, Cuba could become a kind of natural experiment
providing one of the rare situations in which long life
expectancy, low infant mortality and intensive vaccina-
tion coverage, typical of northern wealthy populations,
are coincident with the high antigenic load of a tropical














Figure 1 Distribution of lymphocytes counts from CMV-IgG
seropositive individuals. The linear regression results for males
(blue line, n=53) and female (red line, n=47), the corresponding p
values are shown on the graphs nearby each regression line, p<0.05
indicates statistical differences.Results
Prevalence of CMV-IgG seropositivity
CMV-IgG seropositivity was determined in all indivi-
duals (n=112). The overall prevalence of seropositive
individuals was 90.1% ( n=101). Antibodies against CMV
were found in more than 90% of old individuals no mat-
ter the gender. However in younger ages, there was a
higher frequency of seropositive in males (93.3%) than in
females (73.6%), although statistical significance was not
achieved (Fisher test, p>0.05).Eleven subjects (8 females and 3 males) distributed
within both age groups, were CMV-IgG seronegatives.
As a consequence of their low prevalence in each age/
gender group, it was not possible to establish compari-
sons between seronegative and seropositive individuals
in each group. In consequence, they were omitted in the
subsequent analysis.
Significant decline of total lymphocyte counts with age in
CMV seropositive Cubans is driven by the female group
There was a significant decline with age of the total
lymphocyte counts in CMV seropositive individuals for
the whole population. However, this decline was signifi-
cant only for females (Figure 1), showing higher lympho-
cyte counts in younger ages than the young males (Man
Whitney test, p<0.05). In contrast, males had the lympho-
cyte counts practically constant at all ages.
When lymphocytes were further subdivided into B cells
(CD19+) and T cells (CD4+ and CD8+), the decline in
lymphocyte counts with age was evident only in CD4+
and CD19+ subgroups (Figure 2A). Significant decline in
counts of each subset with age were observed only in
females (Figure 2B). In fact, females displayed higher
counts of T and B cells than males in young ages, being
significant for B cells (Mann Whitney test p<0.05).
Conversely, in old ages males had higher quantities of
CD8 T cells than females (Figura 2C). The counterbal-
ance between genders justifies the no variation in CD8T
cell counts with age.
No changes in the ratio of CD4+:CD8+ T cells with
age were observed in the CMV seropositive individuals
included in the previous analysis. None of the seronega-
tive individuals showed inversion in the CD4+:CD8+






















































































Figure 2 Absolute counts of B and T cells subsets in healthy Cuban subjects. A) CD4, CD8 and CD19 lymphocytes distribution by ages. The
cell markers that PBL were stained for are represented on the Y axis in different colors. The linear regression results for CD19+ (green line, n=94,
CD8+ (blue line, n=99) and CD4+ cells (red line, n=94) and the p values are shown on the graphs nearby each regression line, p<0.05 indicates
statistical differences. B) Absolute counts of CD4, CD8 and CD19 lymphocytes subsets by gender and group of age, significant differences
between young (dark gray) and aged individuals (light gray) in each case are labeled. C) Differences between males (dark gray) and females
(light gray) by age groups. (*) indicate significant differences by Mann Whitney test (p<0.05).























Figure 3 Frequency distribution of CD57+ cells within total
CD8+ T cells. The cell markers that PBL were stained for are shown
on the Y axis. The linear regression results are represented in
different colors for all individuals (black line, n=94), males (blue line,
n=52) and females (red line, n= 42). The p values for all individuals
are shown on the graphs nearby the regression line, p<0.05
indicates statistical differences.
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quency of inversion (8.9%, n=9). A higher prevalence of
an inverted CD4+:CD8+ ratio was found in the aged
group (10.9% vs 3.6% in the youngest) and the highest
frequency was observed in elder males. However, no
significant differences were found applying a Fisher test.
Significant increase in the proportion of activated and
differentiated CD8 T cells with age
The proportion of activated CD8+ T cells increased with
age, but this increase was significant only in males
(Figure 3).
Moreover, the proportion of differentiated CD8+ T
lymphocytes increased with age (Figure 4). In addition to
activated CD8+T cells, the increase was only significant in
males. In contrast, women kept the proportions of CD8+
CD57+ and CD8+CD28- T cells nearly constant at all ages.
Variation of terminally differentiated CD45RA+ CD28- T
cells with age and gender
The expression of CD45 together with the loss of CD28
is a marker of terminally differentiated T lymphocytes




















Figure 4 Frequency distribution of CD28- cells within total CD8+
T cells. The cell markers that PBL were stained for are shown on
the Y axis. The linear regression results are represented in different
colors for all individuals (black line, n=88), males (blue line, n=48)
and females (red line, n= 40). The p values for all individuals are
shown on the graphs nearby the regression line, p<0.05 indicates
statistical differences..
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increased with age both in males and females (Figure 5A).
For CD8+ T cells this increase in terminally differentiated
cells with age was significant only in females (Figure 5B).
Cuban males showed a higher proportion of terminally
differentiated T cells than females since youth ages. In
fact, young males displayed higher frequencies of
CD45RA+CD28- T cells than young females within both
CD4+ (p=0.063) and CD8+ (p=0.015) T cell subsets
(Mann Whitney test p<0.05). However in elder popula-
tions, significant differences (p=0.027) were found only
within CD8+ T lymphocytes. Indeed, elder males had a
higher frequency of CD8+CD45RA+CD28- than elder
females (Figure 5C).
Discussion
Changes in cells of the immune system related to age
have been the subject of many studies in the last two
decades [18-22].Most published studies document a
decrease in the number and proportion of naïve CD8 T
cells in aged individuals together with a reciprocal
increase in memory CD8 T cells [4,23]. These facts have
been frequently associated to a seropositive response to
CMV [24]. There are also recent data showing a decline
in peripheral naive CD4 T cells number with age [11]
and a recent study showed that CMV infection signifi-
cantly increases the proportion of effector memory-like
CD4+ T cells in elder humans [8].
Another study of 1,468 community-dwelling elderly
Latinos, showed that increasing CMV IgG antibody
titers were associated with the overall cause of mortality
even after adjusting for various covariates such as age,
gender, education, and baseline health conditions [25].The CMV persistent infection has been considered as
one of the major drivers of immunosenescence [26] and
such study also contributes to the growing evidence that
CMV immune response is related to the deleterious
processes involved in aging.
The hallmarks of immunosenescence would be
affected by the history of the individual’s exposure to
pathogens [16]. The Cuban population could be a
particular case worth to study, where exceptionally the
high antigenic load typical of a developing country in
the tropical belt is coincident with low infant mortality,
high life expectancy [27] and an aged demographic pyra-
mid [28], as a consequence of social interventions.
The high prevalence of CMV infection in tropical
countries has been attributed to several sociocultural
behaviors that may predispose to increased transmission
of human CMV in early ages of life [29]. A high preva-
lence of seropositivity to cytomegalovirus in Cubans,
after hemodialysis, HIV infection and renal transplants
has been previously described [30-32]. The present study
is the first one to evaluate the immunosenescence
markers in Cubans. We also confirmed a high seropreva-
lence of CMV infection in our population since young
ages, but in this case in healthy individuals.
We found age-associated decreases in the counts of
total lymphocytes, both in B (CD19+) and T cells (CD4+
and CD8+ T cells). These findings are very similar to
previous results showing a significant decline of total
lymphocytes with age [33] as a consequence of the
contraction of T [34] and B cell populations [35]. In
addition, we found gender differences consisting of a
significant decline in the lymphocytes number with age, in
females, and not in males.
Differences in the immune system functioning in
males and females have been previously described
[36,37]. Such differences may occur due to the opposing
ways in which hormones act [38,39]. In fact, Th1 and
Th2 responses appear affected by androgenic and estro-
genic preponderance, respectively. While androgens
favor the development of a Th1 response and the activa-
tion of CD8 cells [40]; estrogens seem to direct the
immune system towards a Th2 dominance, where B
lymphocytes are activated [39]. Those findings are in line
with the higher levels of B cells found in Cuban females,
and in the increased frequency of differentiated CD8 T
cells in males since young ages.
Furthermore, hormonal differences seem the most
probable cause of gender-related changes in the rate of
thymus involution. Male sexual hormones have been
shown to accelerate thymus involution more profoundly
than female hormones, according to reports of improved
thymus function in male gonadectomized mice [41].
While the thymus made fewer new cells with age in both
sexes, women still had higher levels of new T cells than












































































Figure 5 Frequency of highly differentiated T cells according to ages and genders. A) Linear regression shows the percentages of
CD45RA+/CD28- population within total CD4+ T cells for all individuals (black line, n=54), males (blue line, n=31) and females (red line, n=23),
p values are shown on the graphs to each regression line. B) Linear regression shows the percentages of the CD45RA+/CD28- population within
total CD8+ T cells for all individuals (black line, n= 79), males (blue line, n=51) and females (red line, n=28), p values are shown on the graphs to
each regression line. p<0.05 indicates statistical differences. C) Frequency of highly differentiated T cells (within CD4+ and CD8+ subsets) in males
and females by age groups. Differences between males (dark gray) and females (light gray) are represented. * indicates significant differences by
Mann Whitney test (p<0.05).
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between the sexes (such as weight, lifestyle, smoking,
and medication) could also account for the differences
observed [13]. In addition, several studies in mice
showed a more vigorous humoral and cellular immune
responses in females than in males [42,43], and a supe-
rior ability of females to fight infections [44,45]. All
these findings are in line with our results on gender
differences in B and T cell compartments.
In our study the main markers of immunosenescence
in CMV seropositive males were those related to the pro-
portion of CD8 differentiated T cells. The age-associated
increase in the proportion of CD8+/CD57+ cells, express-
ing down modulation of cytotoxic activity, and in terminally
differentiated CD8+/CD28- T cells were only observed in
males. Lenkei and Andersson reported a correlation of
CMV antibody titers with lymphocyte activation status andCD57+ expression [46]. Some studies from Merino et al.
reported that expansion of CD8+CD57+CD28- cells was
related to age, and also to CMV carrier status possibly
related to repeated antigenic stimulation [47]. However
these previous studies did not report influence of gender
on differentiation markers.
Additionally, It is known that during ageing and after
CMV infection there is an increase of highly differenti-
ated CD45RA re-expressing T cells within both the CD4
and CD8 compartments [48-50], This observations may
reflect the impact of thymic involution compounded
with persistent CMV infection during ageing [2]. We
also found increasing proportions of terminally differen-
tiated CD8+/CD45RA+/CD28- T cells with age, but only
significant in females, while males showed a higher
proportion of these cells compared to females of young
ages. Concerning terminally differentiated CD4 T
Table 1 Age and gender distribution of healthy
volunteers
Age group Total Male Female
Young (19–57) 34 15 19
Old (61–103) 78 41 37
Total 112 56 56
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increase in both sexes and a higher proportion of
CD4+/CD45RA+/CD28- T cells also in males.
There have been many studies on the CMV-specific
CD8+ T cell population [24,51-53] and some about the
characteristics of CMV-specific CD4+ T cells describing
the impact that CMV infection has in shaping the T cell
pool [11,54,55]. The majority of highly differentiated T
cell populations in CMV-infected subjects are CMV
specific but there are also increased numbers of these
effector T cells that are specific for other viruses, i.e.
EBV, HSV and VZV [8]. This put forward that CMV
infection may drive a global increase in T cell differenti-
ation suggesting a bystander phenomenon [8]. Alterna-
tively, this could be due to an epidemiological coincidence
of infections with diverse viruses. This hypothesis deserves
further testing in Cuban population where a high sero-
prevalence of herpesviruses (CMV, herpes simplex type 1
virus (HSV) and Epstein Barr virus(EBV) infection has
been previously described [30-32,56].
To our knowledge, the impact of gender in shaping
the T cell pool in CMV infected healthy humans has
not been described before. The lower proportion of
CD45RA+ CD28- T cells (both CD4 and CD8) exhibited
by females during young ages and the high frequency of
highly differentiated CD8 T cells sustained since young
ages in males, is probably linked to gender differences in
the contribution of thymic emigrants to the peripheral
T cell pool with age previously reported by different au-
thors [57-59]. This is also shown by persistent higher
values of signal-joint T cell receptor rearrangement exci-
sion circles (sjTREC) in females between the ages of 20
and 50, and suggesting that the thymic output is
prolonged at higher levels in females as compared with
males [12]. On the other hand, a very recent and unpub-
lished study in Cuban patients (including more than 50%
of pediatric samples) with mononucleosis syndrome,
found higher seroprevalence of CMV (>79%) and EBV
(64,8%) than of HSV (author personal communication).
Consequently with this finding, we think that a higher
exposure to antigenic loads +since infancy in Cuban
population could drive a premature immunosenescence.
This phenomenon could occur essentially in males, which
could be potentially less protected, since male sexual
hormones have been shown to accelerate thymus involu-
tion more deeply than female hormones [41].
The gender contrast in our study, points to a conser-
vation of the output of naive cells until advanced ages in
females, and a higher impact of antigen-driven differen-
tiation of T cells in males probably due to genetic and
environmental factors related to the control of lifespan.
In fact, recent findings indicate that gender is a major
variable in the genetics of longevity, suggesting in turn
that men and women follow different strategies to reachlongevity [60,61]. These gender differences in the immu-
nosenescence process remain significant even inside a
population with high prevalence of CMV seropositivity
in both sexes. Future studies should include the analysis
of naive T cells and TRECS in both gender groups.
In elder population the differences in gender were
found mainly for the differentiated CD8+T cells, where
males showed again the highest proportion. However, in
general we found a broader spectrum of changes with
age in females rather than in males. Conversely, other
studies in humans showed that changes observed with
ageing were more apparent in males [14,15] but the
evidences are statistically significant only for a decrease
of CD8+ alpha beta T cells and for an increase of the
effector memory cells (CD3+CD45RA-CCR7-) [15]. Wikby
et al examined immune parameters for the adult lifespan
and some of their major findings were a higher frequency
of individuals with an inverted CD4/CD8 ratio and lower
levels of CD3+CD4+ and CD8+CD45RA+CCR7+ cells in
men than in women [14]. It should be noticed that these
studies evaluated different markers, and targeted human
populations with lower life-long antigenic load, which
could explain such dissimilar results.
Gender differences in the performance of the immune
system have been suggested long time ago by epide-
miological evidences such as the higher incidence of
autoimmune diseases in females, and atherosclerosis-
related diseases (linked to chronic inflammation) in
males. However, the interplay among hormones, im-
munity and inflammation is so complex that resists any
simple mechanistic interpretation.
Cancer vaccine clinical trials from our own group have
previously shown that age is related to the survival ad-
vantage conferred by therapeutic vaccination with an
immunogenic preparation containing human Epidermal
Growth Factor [62].
Our data, together with previous findings on the role
of gender in the genetic determinants of longevity
[61,63] and the gender-specific age-related remodeling
of the cytokine network [64] indicate the need for
deeper studies on gender-specific immunosenescence
phenotypes to further explore their impact on immuno-
therapy and the potential relevance for personalized
medicine. Such studies in naive and treated cancer
patients are currently ongoing.
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Subjects
Peripheral blood samples were collected from healthy
volunteers by venipuncture.
Subjects were regarded as being healthy if they had no
acute illness, and were on no medication other than
anti-hypertensive medication, and had no serious prior
illnesses. The age and sex distribution of the subjects are
summarized in Table 1.
Individuals younger than 60 years old were defined as
young (median age 34 years old); while individuals older
than 60 years old were defined as elder (median age 77.5
years old).White blood cells collection and staining for flow
cytometry
Red cells were isolated from whole blood with lysing solu-
tion (NH4Cl, EDTA (tetrasodium), KHCO3). White blood
cells (WBCs) were washed twice with Citometry solution
(PBS, BSA, Azide 20%). Specific antibodies against CD3,
CD4, CD8, CD19, CD45RA, CD28 and CD57 molecules,
conjugated either to FITC, PE and Cy5, were purchased
from Serotec and used for staining.
For surface staining, WBCs (1 × 105 cells in 100 μL
Citometry solution) were incubated with 1 μL of the anti-
body in the dark at 4°C for 20 min. Subsequently, cells
were washed twice and analyzed on a three-color flow
cytometer (FACS Scan), with gating on the total lymphoid
populations. Samples were obtained and studied indivi-
dually. All the data generated was obtained from fresh
samples.CMV serology
Serum IgG antibodies to CMV were measured with an
enzyme immunoassay (ETI-CYTOK-G PLUS P002033,
DiaSorin) and expressed as arbitrary units/ml (UI/mL).
A tested result higher than 0.4 UI/mL was considered
positive for the presence of CMV-specific IgG anti-
bodies, as per the manufacturer’s guidelines.Statistical analysis
The relationship between age in years and the absolute
counts of cells with different cell surface markers was
studied by linear regression analysis. Statistical signifi-
cance between groups was evaluated using nonparamet-
ric Kruskal-Wallis test within One-way ANOVA or
Mann Whitney test. Post hoc paired comparisons with
Dunn’s Multiple Comparison Test were done for the
variables that showed differences between groups after
ANOVA analysis. All statistical analyses were performed
with SPSS v15.0 and GraphPad 5. The statistical data
were considered significant if p < 0.05.Abbreviations
CMV: Cytomegalovirus; WBCs: White blood cells; PBL: Peripheral blood
Lymphocytes.
Competing interest
The authors declare that they have no competing interests.
Authors’ contributions
TB performed the analysis, BG and DS supervised the FACS analysis, BG and
IL was responsible for recruiting, consenting subjects and contributed to the
recruitment of subjects and to the development of the study, PL performed
and supervises the statistical analysis, AL, ZM and TC has overall
responsibility for the project, BG, DS and AL has overall responsibility for
writing the paper. All authors read and approved the final manuscript.
Acknowledgements
We are grateful for the assistance of physician and nurses at Hogar Clínica
San Rafael and Hogar Hermanas Giralt in the collection of blood samples of
elderly individuals. Thanks to the younger volunteers from Center of
Molecular Immunology. We are grateful also for the assistance of Professor
Arne Akbar from UCL in UK, for his contribution to the design of this
research. The authors thank Olga Gonzalez and Lila Castellano for the
language corrections of the document.
Received: 26 December 2012 Accepted: 21 April 2013
Published: 30 April 2013
References
1. Shin H, Wherry EJ: CD8 T cell dysfunction during chronic viral infection.
Curr Opin Immunol 2007, 19(4):408–415.
2. McElhaney JE, Effros RB: Immunosenescence: what does it mean to health
outcomes in older adults? Curr Opin Immunol 2009, 21(4):418–424.
3. Pawelec G, Solana R: Immunosenescence. Immunol Today 1997,
18(11):514–516.
4. Wikby A, Johansson B, Olsson J, Lofgren S, Nilsson BO, Ferguson F:
Expansions of peripheral blood CD8 T-lymphocyte subpopulations and
an association with cytomegalovirus seropositivity in the elderly: the
Swedish NONA immune study. Exp Gerontol 2002, 37(2–3):445–453.
5. Olsson J, Wikby A, Johansson B, Lofgren S, Nilsson BO, Ferguson FG: Age-
related change in peripheral blood T-lymphocyte subpopulations and
cytomegalovirus infection in the very old: the Swedish longitudinal
OCTO immune study. Mech Ageing Dev 2000, 121(1–3):187–201.
6. Akbar AN, Fletcher JM: Memory T cell homeostasis and senescence
during aging. Curr Opin Immunol 2005, 17(5):480–485.
7. Appay V, van Lier RA, Sallusto F, Roederer M: Phenotype and function of
human T lymphocyte subsets: consensus and issues. Cytometry A 2008,
73(11):975–983.
8. Libri V, Azevedo RI, Jackson SE, Di Mitri D, Lachmann R, Fuhrmann S,
Vukmanovic-Stejic M, Yong K, Battistini L, Kern F, et al: Cytomegalovirus
infection induces the accumulation of short-lived, multifunctional CD4
+CD45RA+CD27+ T cells: the potential involvement of interleukin-7 in
this process. Immunology 2011, 132(3):326–339.
9. Steinmann GG, Klaus B, Muller-Hermelink HK: The involution of the ageing
human thymic epithelium is independent of puberty. A morphometric
study. Scand J Immunol 1985, 22(5):563–575.
10. Aspinall R, Andrew D: Thymic involution in aging. J Clin Immunol 2000,
20(4):250–256.
11. Weinberger B, Lazuardi L, Weiskirchner I, Keller M, Neuner C, Fischer KH,
Neuman B, Wurzner R, Grubeck-Loebenstein B: Healthy aging and latent
infection with CMV lead to distinct changes in CD8+ and CD4+ T-cell
subsets in the elderly. Hum Immunol 2007, 68(2):86–90.
12. Pido-Lopez J, Imami N, Aspinall R: Both age and gender affect thymic
output: more recent thymic migrants in females than males as they age.
Clin Exp Immunol 2001, 125(3):409–413.
13. Oraei M, Aghamohammadi A, Rezaei N, Bidad K, Gheflati Z, Amirkhani A,
Abolhassani H, Massoud A: Naive CD4+ T cells and recent thymic
emigrants in common variable immunodeficiency. J Investig Allergol Clin
Immunol 2012, 22(3):160–167.
14. Wikby A, Mansson IA, Johansson B, Strindhall J, Nilsson SE: The immune risk
profile is associated with age and gender: findings from three Swedish
García Verdecia et al. Immunity & Ageing 2013, 10:16 Page 8 of 9
http://www.immunityageing.com/content/10/1/16population studies of individuals 20-100 years of age. Biogerontology
2008, 9(5):299–308.
15. Yan J, Greer JM, Hull R, O’Sullivan JD, Henderson RD, Read SJ, McCombe PA:
The effect of ageing on human lymphocyte subsets: comparison of
males and females. Immun Ageing 2010, 7:4.
16. Pawelec G: Hallmarks of human “immunosenescence”: adaptation or
dysregulation? Immun Ageing 2012, 9(1):15.
17. Akbar AN, Henson SM: Are senescence and exhaustion intertwined or
unrelated processes that compromise immunity? Nat Rev Immunol 2011,
11(4):289–295.
18. Effros RB, Boucher N, Porter V, Zhu X, Spaulding C, Walford RL, Kronenberg
M, Cohen D, Schachter F: Decline in CD28+ T cells in centenarians and in
long-term T cell cultures: a possible cause for both in vivo and in vitro
immunosenescence. Exp Gerontol 1994, 29(6):601–609.
19. Huppert FA, Solomou W, O’Connor S, Morgan K, Sussams P, Brayne C:
Aging and lymphocyte subpopulations: whole-blood analysis of immune
markers in a large population sample of healthy elderly individuals.
Exp Gerontol 1998, 33(6):593–600.
20. Weng NP: Aging of the immune system: how much can the adaptive
immune system adapt? Immunity 2006, 24(5):495–499.
21. Czesnikiewicz-Guzik M, Lee WW, Cui D, Hiruma Y, Lamar DL, Yang ZZ,
Ouslander JG, Weyand CM, Goronzy JJ: T cell subset-specific susceptibility
to aging. Clin Immunol 2008, 127(1):107–118.
22. Kumar R, Burns EA: Age-related decline in immunity: implications for
vaccine responsiveness. Expert Rev Vaccines 2008, 7(4):467–479.
23. Kern F, Khatamzas E, Surel I, Frommel C, Reinke P, Waldrop SL, Picker LJ,
Volk HD: Distribution of human CMV-specific memory T cells among the
CD8pos. subsets defined by CD57, CD27, and CD45 isoforms. Eur J
Immunol 1999, 29(9):2908–2915.
24. Chidrawar S, Khan N, Wei W, McLarnon A, Smith N, Nayak L, Moss P:
Cytomegalovirus-seropositivity has a profound influence on the
magnitude of major lymphoid subsets within healthy individuals.
Clin Exp Immunol 2009, 155(3):423–432.
25. Roberts ET, Haan MN, Dowd JB, Aiello AE: Cytomegalovirus antibody
levels, inflammation, and mortality among elderly Latinos over 9 years
of follow-up. Am J Epidemiol 2010, 172(4):363–371.
26. Solana R, Tarazona R, Aiello AE, Akbar AN, Appay V, Beswick M, Bosch JA,
Campos C, Cantisan S, Cicin-Sain L, et al: CMV and Immunosenescence:
from basics to clinics. Immun Ageing 2012, 9(1):23.
27. De Vos P, Garcia-Farinas A, Alvarez-Perez A, Rodriguez-Salva A, Bonet-
Gorbea M, Van der Stuyft P: Public health services, an essential
determinant of health during crisis. Lessons from Cuba, 1989-2000.
Trop Med Int Health 2012, 17(4):469–479.
28. Coyula M: Havana: aging in an aging city. MEDICC Rev 2010, 12(4):27–29.
29. Kouri V, Correa CB, Verdasquera D, Martinez PA, Alvarez A, Aleman Y, Perez
L, Golpe MA, Someilan T, Chong Y, et al: Diagnosis and screening for
cytomegalovirus infection in pregnant women in Cuba as prognostic
markers of congenital infection in newborns: 2007-2008. Pediatr Infect Dis
J 2010, 29(12):1105–1110.
30. Marrero M, Alvarez M, Suarez L, Diaz-Jidi M, Kouri V: Serologic response to
some herpesviruses in a group of HIV infected patients. Rev Cubana Med
Trop 1992, 44(3):208–211.
31. Resik S, Enamorado A, Tallo Y, Suarez C, Kouri V, Acosta B, Garcia S:
Prevalence of antibodies against herpes simplex virus, Epstein-Barr virus
and cytomegalovirus in a group of patients after hemodialysis.
Rev Cubana Med Trop 1999, 51(3):172–176.
32. Glenn J: Cytomegalovirus infections following renal transplantation.
Rev Infect Dis 1981, 3(6):1151–1178.
33. Dorshkind K, Swain S: Age-associated declines in immune system
development and function: causes, consequences, and reversal.
Curr Opin Immunol 2009, 21(4):404–407.
34. Bender BS, Tallman E: The heterogeneity of the age-related decline in immune
response: impairment in delayed-type hypersensitivity and cytotoxic T-
lymphocyte activity occur independently. Exp Gerontol 1992, 27(3):347–354.
35. Cancro MP, Hao Y, Scholz JL, Riley RL, Frasca D, Dunn-Walters DK, Blomberg
BB: B cells and aging: molecules and mechanisms. Trends Immunol 2009,
30(7):313–318.
36. Grossman CJ: Regulation of the immune system by sex steroids.
Endocr Rev 1984, 5(3):435–455.
37. Pietschmann P, Gollob E, Brosch S, Hahn P, Kudlacek S, Willheim M,
Woloszczuk W, Peterlik M, Tragl KH: The effect of age and gender oncytokine production by human peripheral blood mononuclear cells and
markers of bone metabolism. Exp Gerontol 2003, 38(10):1119–1127.
38. Whitacre CC: Sex differences in autoimmune disease. Nat Immunol 2001,
2(9):777–780.
39. McCarthy M: The “gender gap” in autoimmune disease. Lancet 2000,
356(9235):1088.
40. Beagley KW, Gockel CM: Regulation of innate and adaptive immunity by
the female sex hormones oestradiol and progesterone. FEMS Immunol
Med Microbiol 2003, 38(1):13–22.
41. Hince M, Sakkal S, Vlahos K, Dudakov J, Boyd R, Chidgey A: The role of sex
steroids and gonadectomy in the control of thymic involution.
Cell Immunol 2008, 252(1–2):122–138.
42. Ansar Ahmed S, Penhale WJ, Talal N: Sex hormones, immune responses,
and autoimmune diseases. Mechanisms of sex hormone action.
Am J Pathol 1985, 121(3):531–551.
43. Weinstein Y, Ran S, Segal S: Sex-associated differences in the regulation of
immune responses controlled by the MHC of the mouse. J Immunol
1984, 132(2):656–661.
44. Lotter H, Jacobs T, Gaworski I, Tannich E: Sexual dimorphism in the control
of amebic liver abscess in a mouse model of disease. Infect Immun 2006,
74(1):118–124.
45. Mock BA, Nacy CA: Hormonal modulation of sex differences in resistance to
Leishmania major systemic infections. Infect Immun 1988, 56(12):3316–3319.
46. Lenkei R, Andersson B: High correlations of anti-CMV titers with
lymphocyte activation status and CD57 antibody-binding capacity as
estimated with three-color, quantitative flow cytometry in blood donors.
Clin Immunol Immunopathol 1995, 77(2):131–138.
47. Merino J, Martinez-Gonzalez MA, Rubio M, Inoges S, Sanchez-Ibarrola A,
Subira ML: Progressive decrease of CD8high+ CD28+ CD57- cells with
ageing. Clin Exp Immunol 1998, 112(1):48–51.
48. Khan N, Shariff N, Cobbold M, Bruton R, Ainsworth JA, Sinclair AJ, Nayak L,
Moss PA: Cytomegalovirus seropositivity drives the CD8 T cell repertoire
toward greater clonality in healthy elderly individuals. J Immunol 2002,
169(4):1984–1992.
49. Wills MR, Okecha G, Weekes MP, Gandhi MK, Sissons PJ, Carmichael AJ:
Identification of naive or antigen-experienced human CD8(+) T cells by
expression of costimulation and chemokine receptors: analysis of the
human cytomegalovirus-specific CD8(+) T cell response. J Immunol 2002,
168(11):5455–5464.
50. Derhovanessian E, Maier AB, Hahnel K, Beck R, de Craen AJ, Slagboom EP,
Westendorp RG, Pawelec G: Infection with cytomegalovirus but not
herpes simplex virus induces the accumulation of late-differentiated
CD4+ and CD8+ T-cells in humans. J Gen Virol 2011, 92(Pt 12):2746–2756.
51. Appay V, Dunbar PR, Callan M, Klenerman P, Gillespie GM, Papagno L, Ogg
GS, King A, Lechner F, Spina CA, et al: Memory CD8+ T cells vary in
differentiation phenotype in different persistent virus infections. Nat Med
2002, 8(4):379–385.
52. Gamadia LE, Rentenaar RJ, Baars PA, Remmerswaal EB, Surachno S, Weel JF,
Toebes M, Schumacher TN, ten Berge IJ, van Lier RA: Differentiation of
cytomegalovirus-specific CD8(+) T cells in healthy and
immunosuppressed virus carriers. Blood 2001, 98(3):754–761.
53. Pita-Lopez ML, Gayoso I, DelaRosa O, Casado JG, Alonso C, Munoz-Gomariz
E, Tarazona R, Solana R: Effect of ageing on CMV-specific CD8 T cells from
CMV seropositive healthy donors. Immun Ageing 2009, 6:11.
54. Pourgheysari B, Khan N, Best D, Bruton R, Nayak L, Moss PA: The
cytomegalovirus-specific CD4+ T-cell response expands with age and
markedly alters the CD4+ T-cell repertoire. J Virol 2007, 81(14):7759–7765.
55. Fletcher JM, Vukmanovic-Stejic M, Dunne PJ, Birch KE, Cook JE, Jackson SE,
Salmon M, Rustin MH, Akbar AN: Cytomegalovirus-specific CD4+ T cells in
healthy carriers are continuously driven to replicative exhaustion.
J Immunol 2005, 175(12):8218–8225.
56. Correa CB, Kouri V, Verdasquera D, Martinez PA, Alvarez A, Aleman Y, Perez
L, Viera J, Gonzalez R, Perez E, et al: HCMV seroprevalence and associated
risk factors in pregnant women, Havana City, 2007 to 2008. Prenat Diagn
2010, 30(9):888–892.
57. Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, Haynes BF,
Polis MA, Haase AT, Feinberg MB, Sullivan JL, et al: Changes in thymic
function with age and during the treatment of HIV infection.
Nature 1998, 396(6712):690–695.
58. Aspinall R, Pido J, Andrew D: A simple method for the measurement of
sjTREC levels in blood. Mech Ageing Dev 2000, 121(1–3):59–67.
García Verdecia et al. Immunity & Ageing 2013, 10:16 Page 9 of 9
http://www.immunityageing.com/content/10/1/1659. Whitacre CC, Reingold SC, O’Looney PA: A gender gap in autoimmunity.
Science 1999, 283(5406):1277–1278.
60. Lio D, Scola L, Crivello A, Colonna-Romano G, Candore G, Bonafe M,
Cavallone L, Franceschi C, Caruso C: Gender-specific association between -
1082 IL-10 promoter polymorphism and longevity. Genes Immun 2002,
3(1):30–33.
61. Balistreri CR, Candore G, Accardi G, Bova M, Buffa S, Bulati M, Forte GI,
Listi F, Martorana A, Palmeri M, et al: Genetics of longevity. data from the
studies on Sicilian centenarians. Immun Ageing 2012, 9(1):8.
62. Garcia B, Neninger E, de la Torre A, Leonard I, Martinez R, Viada C,
Gonzalez G, Mazorra Z, Lage A, Crombet T: Effective inhibition of the
epidermal growth factor/epidermal growth factor receptor binding by
anti-epidermal growth factor antibodies is related to better survival in
advanced non-small-cell lung cancer patients treated with the epidermal
growth factor cancer vaccine. Clin Cancer Res 2008, 14(3):840–846.
63. Candore G, Balistreri CR, Listi F, Grimaldi MP, Vasto S, Colonna-Romano G,
Franceschi C, Lio D, Caselli G, Caruso C: Immunogenetics, gender, and
longevity. Ann N Y Acad Sci 2006, 1089:516–537.
64. Vasto S, Candore G, Balistreri CR, Caruso M, Colonna-Romano G, Grimaldi
MP, Listi F, Nuzzo D, Lio D, Caruso C: Inflammatory networks in ageing,
age-related diseases and longevity. Mech Ageing Dev 2007, 128(1):83–91.
doi:10.1186/1742-4933-10-16
Cite this article as: García Verdecia et al.: Immunosenescence and
gender: a study in healthy Cubans. Immunity & Ageing 2013 10:16.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
